Nina Schultz is a Principal Research Scientist and head of Biomarkers at Vesper Bio, specializing in neurobiology with a focus on neurodegenerative diseases. With seven years of experience studying the impact of amyloid peptides and two years exploring selective vulnerability related to protein homeostasis, Nina has significantly contributed to the field through 15 publications in renowned journals. Previously, they held postdoctoral positions at the University of California, San Francisco, and Lund University, and have worked as a Research Assistant at Region Skåne. Nina holds a PhD in Neurobiology from Lund University and has a strong foundation in biomarker analysis and various biological techniques. Currently, they serve as a Review Editor for Frontiers in Neuroscience.
This person is not in the org chart
This person is not in any teams
This person is not in any offices